Equities research analysts at StockNews.com began coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Get Rating) in a research report issued to clients and investors on Thursday. The brokerage set a “sell” rating on the stock. Ampio Pharmaceuticals Price Performance Ampio Pharmaceuticals Company Profile (Get Rating) Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for […]